Effects of iron complexes on brain calcium homeostasis
Identifieur interne : 001736 ( PascalFrancis/Corpus ); précédent : 001735; suivant : 001737Effects of iron complexes on brain calcium homeostasis
Auteurs : L. J. Anghileri ; P. Thouvenot ; A. BertrandSource :
- Annals of clinical and laboratory science [ 0091-7370 ] ; 1997.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca2+ homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca2+ homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca2+ homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 97-0299238 INIST |
---|---|
ET : | Effects of iron complexes on brain calcium homeostasis |
AU : | ANGHILERI (L. J.); THOUVENOT (P.); BERTRAND (A.) |
AF : | Biophysics Laboratory, Medical Faculty, University of Nancy/Nancy/France (1 aut.); Nuclear Medicine Department, University of Nancy Medical Center/Nancy/France (2 aut., 3 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Annals of clinical and laboratory science; ISSN 0091-7370; Coden ACLSCP; Etats-Unis; Da. 1997; Vol. 27; No. 3; Pp. 210-215; Bibl. 18 ref. |
LA : | Anglais |
EA : | The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca2+ homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca2+ homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca2+ homeostasis modification process. The possible role of this process in Parkinson's disease is discussed. |
CC : | 002B17G |
FD : | Parkinson maladie; Homéostasie phosphocalcique; Calcium; Fer complexe; In vivo; Pathogénie; Animal; Souris; Rat; In vitro; Culture cellulaire |
FG : | Rodentia; Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative |
ED : | Parkinson disease; Phosphocalcic homeostasis; Calcium; Iron complex; In vivo; Pathogenesis; Animal; Mouse; Rat; In vitro; Cell culture |
EG : | Rodentia; Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease |
GD : | Calcium; Eisenkomplex |
SD : | Parkinson enfermedad; Homeostasia fosfocálcica; Calcio; Hierro complejo; In vivo; Patogenia; Animal; Ratón; Rata; In vitro; Cultivo celular |
LO : | INIST-16904.354000065519320060 |
ID : | 97-0299238 |
Links to Exploration step
Pascal:97-0299238Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effects of iron complexes on brain calcium homeostasis</title>
<author><name sortKey="Anghileri, L J" sort="Anghileri, L J" uniqKey="Anghileri L" first="L. J." last="Anghileri">L. J. Anghileri</name>
<affiliation><inist:fA14 i1="01"><s1>Biophysics Laboratory, Medical Faculty, University of Nancy</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Thouvenot, P" sort="Thouvenot, P" uniqKey="Thouvenot P" first="P." last="Thouvenot">P. Thouvenot</name>
<affiliation><inist:fA14 i1="02"><s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bertrand, A" sort="Bertrand, A" uniqKey="Bertrand A" first="A." last="Bertrand">A. Bertrand</name>
<affiliation><inist:fA14 i1="02"><s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">97-0299238</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 97-0299238 INIST</idno>
<idno type="RBID">Pascal:97-0299238</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001736</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effects of iron complexes on brain calcium homeostasis</title>
<author><name sortKey="Anghileri, L J" sort="Anghileri, L J" uniqKey="Anghileri L" first="L. J." last="Anghileri">L. J. Anghileri</name>
<affiliation><inist:fA14 i1="01"><s1>Biophysics Laboratory, Medical Faculty, University of Nancy</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Thouvenot, P" sort="Thouvenot, P" uniqKey="Thouvenot P" first="P." last="Thouvenot">P. Thouvenot</name>
<affiliation><inist:fA14 i1="02"><s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bertrand, A" sort="Bertrand, A" uniqKey="Bertrand A" first="A." last="Bertrand">A. Bertrand</name>
<affiliation><inist:fA14 i1="02"><s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Annals of clinical and laboratory science</title>
<title level="j" type="abbreviated">Ann. clin. lab. sci.</title>
<idno type="ISSN">0091-7370</idno>
<imprint><date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Annals of clinical and laboratory science</title>
<title level="j" type="abbreviated">Ann. clin. lab. sci.</title>
<idno type="ISSN">0091-7370</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term>
<term>Calcium</term>
<term>Cell culture</term>
<term>In vitro</term>
<term>In vivo</term>
<term>Iron complex</term>
<term>Mouse</term>
<term>Parkinson disease</term>
<term>Pathogenesis</term>
<term>Phosphocalcic homeostasis</term>
<term>Rat</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Homéostasie phosphocalcique</term>
<term>Calcium</term>
<term>Fer complexe</term>
<term>In vivo</term>
<term>Pathogénie</term>
<term>Animal</term>
<term>Souris</term>
<term>Rat</term>
<term>In vitro</term>
<term>Culture cellulaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca<sup>2+</sup>
homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca<sup>2+</sup>
homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca<sup>2+</sup>
homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0091-7370</s0>
</fA01>
<fA02 i1="01"><s0>ACLSCP</s0>
</fA02>
<fA03 i2="1"><s0>Ann. clin. lab. sci.</s0>
</fA03>
<fA05><s2>27</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Effects of iron complexes on brain calcium homeostasis</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ANGHILERI (L. J.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>THOUVENOT (P.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BERTRAND (A.)</s1>
</fA11>
<fA14 i1="01"><s1>Biophysics Laboratory, Medical Faculty, University of Nancy</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Nuclear Medicine Department, University of Nancy Medical Center</s1>
<s2>Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>210-215</s1>
</fA20>
<fA21><s1>1997</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>16904</s2>
<s5>354000065519320060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>18 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>97-0299238</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Annals of clinical and laboratory science</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca<sup>2+</sup>
homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca<sup>2+</sup>
homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca<sup>2+</sup>
homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Homéostasie phosphocalcique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Phosphocalcic homeostasis</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Homeostasia fosfocálcica</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="GER"><s0>Calcium</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Calcio</s0>
<s2>NC</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Fer complexe</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Iron complex</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="GER"><s0>Eisenkomplex</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Hierro complejo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>In vivo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>In vivo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>In vivo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Pathogénie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Pathogenesis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Patogenia</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Souris</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Mouse</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Ratón</s0>
<s5>21</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Rat</s0>
<s5>22</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Rat</s0>
<s5>22</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Rata</s0>
<s5>22</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>In vitro</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>In vitro</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>In vitro</s0>
<s5>23</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Culture cellulaire</s0>
<s5>24</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Cell culture</s0>
<s5>24</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Cultivo celular</s0>
<s5>24</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21><s1>167</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 97-0299238 INIST</NO>
<ET>Effects of iron complexes on brain calcium homeostasis</ET>
<AU>ANGHILERI (L. J.); THOUVENOT (P.); BERTRAND (A.)</AU>
<AF>Biophysics Laboratory, Medical Faculty, University of Nancy/Nancy/France (1 aut.); Nuclear Medicine Department, University of Nancy Medical Center/Nancy/France (2 aut., 3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Annals of clinical and laboratory science; ISSN 0091-7370; Coden ACLSCP; Etats-Unis; Da. 1997; Vol. 27; No. 3; Pp. 210-215; Bibl. 18 ref.</SO>
<LA>Anglais</LA>
<EA>The effects of two physiological low molecular weight iron complexes, ferric lactate and ferric adenosine triphosphate (ATP) on brain Ca<sup>2+</sup>
homeostasis modification, have been studied in vitro and in vivo. In vitro ferric ATP complex shows a higher efficiency as modifier of Ca<sup>2+</sup>
homeostasis. This higher reactivity and the in vivo observed effect of increased brain uptake of iron from ferric lactate provoked by the presence of ATP, corroborate in vitro results showing an iron transfer from ferric lactate to ATP, as well as the mediator role of ATP in the iron-induced cellular Ca<sup>2+</sup>
homeostasis modification process. The possible role of this process in Parkinson's disease is discussed.</EA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Homéostasie phosphocalcique; Calcium; Fer complexe; In vivo; Pathogénie; Animal; Souris; Rat; In vitro; Culture cellulaire</FD>
<FG>Rodentia; Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Phosphocalcic homeostasis; Calcium; Iron complex; In vivo; Pathogenesis; Animal; Mouse; Rat; In vitro; Cell culture</ED>
<EG>Rodentia; Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<GD>Calcium; Eisenkomplex</GD>
<SD>Parkinson enfermedad; Homeostasia fosfocálcica; Calcio; Hierro complejo; In vivo; Patogenia; Animal; Ratón; Rata; In vitro; Cultivo celular</SD>
<LO>INIST-16904.354000065519320060</LO>
<ID>97-0299238</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001736 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001736 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:97-0299238 |texte= Effects of iron complexes on brain calcium homeostasis }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |